Stay updated on LBR-101 Efficacy in Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the LBR-101 Efficacy in Chronic Migraine Clinical Trial page.

Latest updates to the LBR-101 Efficacy in Chronic Migraine Clinical Trial page
- Check3 days agoChange DetectedCore study details such as primary/secondary outcomes, eligibility criteria, enrollment, and locations appear unchanged; observed differences seem limited to layout or display elements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check32 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data and transaction delays due to funding lapses; previous v3.1.0 version tag removed.SummaryDifference3%

- Check39 days agoChange DetectedAdded version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.SummaryDifference0.4%

- Check53 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; no substantive content changes detected.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional drug information related to Fremanezumab and various medical topics. Some previous content, including certain MedlinePlus topics and location details, has been removed.SummaryDifference3%

Stay in the know with updates to LBR-101 Efficacy in Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LBR-101 Efficacy in Chronic Migraine Clinical Trial page.